NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy
Intensive, combination chemotherapy for malignant diseases causes a profound immunosuppression, which persists for the whole treatment period and after its completion. Impairment of the NK cells status may increase the risk of severe, disseminated infections and cancer. The aim of the study was the...
Κύριοι συγγραφείς: | Jarosz, M, Hak, L, Wieckiewicz, J, Balcerska, A, Mysliwska, J |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Termedia Publishing House Ltd.
2009
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma
ανά: Amandeep Aujla, κ.ά.
Έκδοση: (2019-04-01) -
Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
ανά: Ali Ghassemi, κ.ά.
Έκδοση: (2016-06-01) -
Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
ανά: Miguel Enrique Cuéllar Mendoza, κ.ά.
Έκδοση: (2024-02-01) -
Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
ανά: Betül Sevinir, κ.ά.
Έκδοση: (2011-03-01) -
Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia
ανά: Betül Sevinir, κ.ά.
Έκδοση: (2011-03-01)